Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Shares Outstanding (Weighted Average) (2020 - 2023)

Historic Shares Outstanding (Weighted Average) for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to $71.5 million.

  • Terns Pharmaceuticals' Shares Outstanding (Weighted Average) rose 8573.64% to $71.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $71.5 million, marking a year-over-year increase of 8573.64%. This contributed to the annual value of $36.0 million for FY2022, which is 5869.43% up from last year.
  • Terns Pharmaceuticals' Shares Outstanding (Weighted Average) amounted to $71.5 million in Q3 2023, which was up 8573.64% from $71.4 million recorded in Q2 2023.
  • In the past 5 years, Terns Pharmaceuticals' Shares Outstanding (Weighted Average) registered a high of $71.5 million during Q3 2023, and its lowest value of $215890.0 during Q1 2020.
  • Moreover, its 4-year median value for Shares Outstanding (Weighted Average) was $25.1 million (2021), whereas its average is $28.5 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first surged by 847542.97% in 2021, then skyrocketed by 77.39% in 2022.
  • Quarter analysis of 4 years shows Terns Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $285162.0 in 2020, then skyrocketed by 7862.47% to $22.7 million in 2021, then soared by 58.69% to $36.0 million in 2022, then surged by 98.51% to $71.5 million in 2023.
  • Its Shares Outstanding (Weighted Average) was $71.5 million in Q3 2023, compared to $71.4 million in Q2 2023 and $69.8 million in Q1 2023.